ProPhase Labs, Inc. (PRPH) Trades at $2.32 After Triangle; Leidos Holdings (LDOS) Sentiment Is 1.15

Leidos Holdings, Inc., a science and technology company, provides technology and engineering solutions in the defense, intelligence, homeland security, civil, and health markets in the United States and internationally. The company has market cap of $10.04 billion. The firm operates through National Security Solutions , Information Systems & Global Solutions (IS&GS), and Health and Infrastructure (HIS) divisions. It has a 32.7 P/E ratio. The NSS segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. intelligence community, the U.S.

ProPhase Labs, Inc. (PRPH) formed triangle with $2.11 target or 9.00% below today’s $2.32 share price. ProPhase Labs, Inc. (PRPH) has $28.83M valuation. The stock increased 3.57% or $0.08 during the last trading session, reaching $2.32. About 16,417 shares traded or 57.72% up from the average. ProPhase Labs, Inc. (NASDAQ:PRPH) has risen 42.75% since January 9, 2017 and is uptrending. It has outperformed by 26.05% the S&P500.

Southpoint Capital Advisors Lp holds 4.79% of its portfolio in Leidos Holdings, Inc. for 1.97 million shares. Junto Capital Management Lp owns 509,652 shares or 2.47% of their US portfolio. Moreover, Aureus Asset Management Llc has 2.26% invested in the company for 241,124 shares. The New York-based Lodge Hill Capital Llc has invested 1.57% in the stock. C M Bidwell & Associates Ltd, a Hawaii-based fund reported 16,400 shares.

Analysts await Leidos Holdings, Inc. (NYSE:LDOS) to report earnings on February, 22. They expect $0.83 EPS, up 10.67% or $0.08 from last year’s $0.75 per share. LDOS’s profit will be $125.56M for 19.99 P/E if the $0.83 EPS becomes a reality. After $0.95 actual EPS reported by Leidos Holdings, Inc. for the previous quarter, Wall Street now forecasts -12.63% negative EPS growth.

Since January 1, 0001, it had 0 buys, and 1 sale for $44,600 activity.

Ratings analysis reveals 67% of Leidos’s analysts are positive. Out of 3 Wall Street analysts rating Leidos, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. LDOS was included in 3 notes of analysts from November 21, 2016. Credit Suisse upgraded the stock to “Outperform” rating in Monday, November 21 report. The stock has “Neutral” rating by Goldman Sachs on Wednesday, December 14. The rating was initiated by Oppenheimer on Tuesday, December 6 with “Outperform”.

The stock increased 2.55% or $1.65 during the last trading session, reaching $66.38. About 751,950 shares traded or 0.38% up from the average. Leidos Holdings, Inc. (LDOS) has risen 45.87% since January 9, 2017 and is uptrending. It has outperformed by 29.17% the S&P500.